Venture Partners V. L. P. Prism serves as Executive at Trius Therapeutics Inc, where they oversee executive responsibilities. Since joining the company, Venture Partners V. L. P. Prism has executed 3 insider transactions totaling $6.0M, demonstrating a bullish approach to their equity position. Their most recent transaction on Aug 6, 2010 involved exercising options for 1,198,378 shares valued at $0.
Venture Partners V. L. P. Prism currently holds 1,198,378 shares of Trius Therapeutics Inc (TSRX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Venture Partners V. L. P. Prism has been a net buyer of TSRX stock. They have purchased $6.0M and sold $0 worth of shares.
Venture Partners V. L. P. Prism's most recent insider trade was on Aug 6, 2010, when they sold 1,198,378 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $4.38 |
| Discretionary |
| Aug 6, 2010 | TSRX | $6.0M | Purchase | 1,194,035 | $5.00 | Discretionary |